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serotypes 1-7 (AD 1-7) and control RNA were detected by multi-
plex RT-PCR. In second multiplex nested RT-PCR influenza viruses
subtypes A and B were differentiated.
Results: Between 12/04 and 1/08 we analyzed a total of 149 NS
collected from 88 patients and 134 BALF collected from 100 pa-
tients. The following pathogens were identified in NS/BALF, re-
spectively: RSV -26/17, AD (1-7) – 1/1, PIV1 – 2/2, PIV2 – 3/1,
PIV 3 – 4/4, FLU A – 9/5 and FLU B – 1/1. Four patients were si-
multaneously infected with two viruses (2 – RSV and FLU A, 2 – RSV
and PIV3).
Conclusions: Presented multiplex RT-PCR assay enables cheap,
rapid and sensitive detection of many pathogens at the same time,
even when mixed infection is present. Using of the internal con-
trol of RNA isolation and sample inhibition ensures that true and
false-negative results are distinguishable in the assay. Although RV
infections were common in our study (23.1% BALF and 30.8% NS
positive) in most patients just symptomatic treatment was needed.
Thus clinical significance of the virus detection needs further eval-
uation.
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Background: VRE are significant nosocomial pathogens in immuno-
compromised pts with hematological malignancies. Continual mon-
itoring of incidence of VRE and targeted prevention are necessary
for improvement of complex care of hemato-oncological patients.
Objectives and Methods: The aim of the study was the retrospec-
tive analysis of phenotypic and clinical epidemiological trends of
VRE at large hemato-oncological department. in Czech Republic
between 2003-2007. At the same time we analyzed antibiotic (ATB)
consumption in the entire period.
Results: During the 5-year period total No. of all patients with VRE
colonization or infection was 186 (vanA – 155, vanB – 31). Blood
Figure 1. Trends in comsumption of antibiotics in 2000–2007.
Figure 2. Trends in colonization and infection caused by VRE in 2000–2007.
cultures (BC) were positive for VRE in 11 cases. In 2004 an exces-
sive outbreak of VRE isolates occurred, both in colonization and
BC (46 – 2003 vs. 111 – 2004). The percentage ratio of VRE from
all enterococci also increased (10% – 2003 vs. 25% – 2004). The %
ratio of VRE from all enterococci in BC also rose (8% – 2003 vs. 40%
– 2004). We identified these possible reasons: 1) enhanced usage
of vancomycin and the third generation (III.g.) cephalosporins in
2000-2002 (average consumption of ATB in PDD/1000 bed-days –
vancomycin: 63, III.gen. ceph.: 59); 2) lack of regimen. This emer-
gence of VRE was reason for institution of appropriate regimen
(including regular detection and isolation of VRE carriers, hand-
hygiene) and marked restriction in usage of the above mentioned
groups of ATB (2005 - vancomycin: 33, III. gen. ceph.: 15). These
precautions led to the significant decrease of VRE in the following
years (2005 - 16 pts. with VRE colonization or infection, 2% VRE
from all isolates of enterococci, 1 VRE in BC, 3% VRE of all entero-
cocci in BC).
Conclusions: Regular detection of VRE carriers, particular judi-
cious use of vancomycin and III. gen. cephalosporins and institu-
tion of appropriate regimen facilitated significant decrease of VRE
at our dpt. and thus resulted in lower morbidity and mortality and
healthcare costs.
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Background: Early sensitive diagnosis of invasive mycoses (IM) in
pts with persistent febrile neutropenia (PFN) is important for tai-
lored use of antifungals and optimizing successful outcome. We
assessed the clinical usefulness of the beta-D-glucan (BG) assay in
patients with PFN at risk from IM.
Materials and Methods: One hundred adults with haematological
malignancy neutropenic (<500/ml) with persistent fever (>38.3 C
>4days) after chemotherapy had alternate day serum assayed for
BG (Cape Cod Assocs). IM diagnosed as per EORTC/MSG criteria. No
pt had antifungal drug prophylaxis. Pts with PFN unresponsive to
antibiotics received empirical treatment with 3mg (increasing to
5-10 for IM) per kg/day liposomal amphotericin B. The mean and
median BG concentrations in the two pt subgroups of PFN alone or
with IM were compared with the Mann-Whitney test. 2x2 contin-
gency tables were analysed with Fisher' s exact test.
Results: IM developed in 38 (14 candidiasis [12 proven/probable,
2 possible], 24 aspergillosis [14 probable, 10 possible], PFN only
in 42 pts. Serum BG was significantly elevated on the first day of
PFN and all subsequent days to day 10 PFN in pts who developed
IM (Figure 1). Median BG was 95.8 and 32.9 pg/ml for patients with
IM and only PFN respectively (p<0.0001). Antifungal therapy did
not affect the values over the first 10 days. There was consider-
able inter-patient variability in BG time-patterns. Using cut-offs of
between 60 and 100 pg/ml, at least 2 sequential values >80 pg/ml
(' positive test' ) gave optimal accuracy of 81%, positive/negative
predictive values respectively of 77/87%. Of pts with IM 78% had
a positive test a mean of 1.25 days prior to IM diagnosis. However
by sampling from the first neutropenic day instead of from PFN,
50% of those with IM were detected 5 days earlier. Daily sampling
did not improve the sensitivity. 73% of pts with at least 2 readings
but without IM had severe mucositis/enterocolitis compared with
19% who had less than 2 readings at least 80 pg/ml (p=0.002). In
most cases the rises in BG were transient (Figure 2). The overall
